Device: magnetic resonance imaging (mri) without gadolinium enhancement (DrugBank: Gadolinium)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
58 | Hypertrophic cardiomyopathy | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02559726 (ClinicalTrials.gov) | June 2015 | 26/6/2015 | Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response | Identification and Quantification of a Mechanical Hyper-synchronicity State in Hypertrophic Cardiomyopathy (HCM) With Left Outflow-tract Obstruction and Description of Its Electrical and Electro-mechanical Characteristics Thanks to an Innovative Multi-imaging Approach to Predict a Positive Response to Dual Chamber Pacing. The Hsync Study. | Hypertrophic Cardiomyopathy;Mechanical Hyper-synchronicity | Procedure: Echocardiography (TEE);Device: Magnetic resonance imaging (MRI) with gadolinium enhancement;Device: Magnetic resonance imaging (MRI) without gadolinium enhancement;Procedure: 3D electrocardiographic mapping (ECM) | University Hospital, Bordeaux | NULL | Recruiting | 18 Years | N/A | Both | 60 | N/A | France |